Cost-utility analysis of emicizumab prophylaxis in haemophilia A patients with factor VIII inhibitors in Korea
- 세원 정
- 2024년 11월 8일
- 1분 분량
[논문] 이한길, Ah-Young Kim, Deborah Baik, Hyeonseok Cho, Jung Woo Han, Minjun Lee, Seonyoung Park, Hye-Young Kang, Cost-utility analysis of emicizumab prophylaxis in haemophilia A patients with factor VIII inhibitors in Korea , HAEMOPHILIA (Jan, 2021)
DOI: 10.1111/hae.14143